News – Jun 04, 2018

EU H2020 grant for unique HIT-Cystic Fibrosis project

The EU has granted 6.7 M€ from the Horizon 2020 research program to a broad collaborative group of researchers, doctors, pharmaceutical companies and patient representatives. Julius Clinical is one of the consortium partners and will be responsible for global Site Management, Monitoring, Data Management and Safety Management for the clinical part of the project. For more details, please click here